DAE HWA Pharmaceutical Co., Ltd.

₩8,820As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:067080Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (9.16%)
Div yield 1.70%
ROE 6.12%
Pharmaceutical Preparations
Beta (5Y) (0.08)
PE TTM 35.55
TSR TTM (45.59%)
Mkt cap ₩162.5B
ROIC 1.95%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩11,280
27.89%
(33.41%)
Sell 0|11|10|10|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
137.38
149.44
154.42
167.75
41.27%
39.35%
28.88%
32.16%
Revenue₩B
11.79
11.59
12.13
12.71
5.30%
3.76%
7.50%
12.41%
Peers (US$119.8M)
Cap (US$)
PE
120.1M
—
109.6M
19.50x
121.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.864
(0.260)
(0.214)
EBIT/Intx
1.631
0.206
0.237
Own earn%
(201.12)
89.10
86.13
Sh yield%
14.19
40.91
36.75
Owners
Insiders/Inst%
4.27
69.73
Short interest%
5.81
SBC / revenue%
0.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
22–28
$1 testx
0.0
Incr. ROIC%
5